Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 6:18 pm Sale | 2025-09-30 | 13G | RAPT Therapeutics, Inc. RAPT | ORBIMED ADVISORS LLC | 1,086,618 6.600% | -555,290 (-33.82%) | Filing History |
| 2025-11-14 4:32 pm Sale | 2025-09-30 | 13G | RAPT Therapeutics, Inc. RAPT | Nantahala Capital Management, LLC | 623,282 3.770% | -328,331 (-34.50%) | Filing History |
| 2025-11-14 4:21 pm Sale | 2025-09-30 | 13G | RAPT Therapeutics, Inc. RAPT | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -1,470,500 (Position Closed) | Filing History |
| 2025-10-30 3:50 pm Purchase | 2025-09-30 | 13G | RAPT Therapeutics, Inc. RAPT | The Vanguard Group | 696,188 4.200% | 696,188 (New Position) | Filing History |
| 2025-10-29 7:51 pm Purchase | 2025-10-23 | 13G | RAPT Therapeutics, Inc. RAPT | ForGrowth III PA B.V. | 1,833,333 7.400% | 1,833,333 (New Position) | Filing History |
| 2025-08-14 4:34 pm Purchase | 2025-06-30 | 13G | RAPT Therapeutics, Inc. RAPT | Nantahala Capital Management, LLC | 951,613 5.750% | 951,613 (New Position) | Filing History |
| 2025-08-14 4:18 pm Purchase | 2025-06-30 | 13G | RAPT Therapeutics, Inc. RAPT | Redmile Group, LLC | 1,765,303 9.900% | 1,765,303 (New Position) | Filing History |
| 2025-05-15 08:00 am Purchase | 2025-03-31 | 13G | RAPT Therapeutics, Inc. RAPT | RTW Investments, LP | 1,470,500 8.900% | 1,470,500 (New Position) | Filing History |
| 2025-04-30 11:11 am Purchase | 2025-03-31 | 13G | RAPT Therapeutics, Inc. RAPT | The Vanguard Group | 1,034,850 6.270% | 668,300 (+182.32%) | Filing History |
| 2025-04-25 6:35 pm Sale | 2025-03-31 | 13G | RAPT Therapeutics, Inc. RAPT | BlackRock Inc. BLK | 288,328 1.700% | -18,303 (-5.97%) | Filing History |
| 2025-02-14 8:02 pm Purchase | 2024-12-31 | 13G | RAPT Therapeutics, Inc. RAPT | Redmile Group, LLC | 1,741,556 9.900% | 1,269,450 (+268.89%) | Filing History |
| 2025-02-14 4:32 pm Purchase | 2024-12-31 | 13G | RAPT Therapeutics, Inc. RAPT | ORBIMED ADVISORS LLC | 1,641,908 9.900% | 1,641,908 (New Position) | Filing History |
| 2025-02-14 4:15 pm Purchase | 2024-12-31 | 13G | RAPT Therapeutics, Inc. RAPT | Perceptive Advisors LLC | 735,000 4.500% | 467,506 (+174.77%) | Filing History |
| 2025-02-07 5:31 pm Sale | 2025-01-31 | 13G | RAPT Therapeutics, Inc. RAPT | The Vanguard Group | 366,550 2.220% | -27,951 (-7.09%) | Filing History |
| 2025-02-07 5:31 pm Sale | 2025-01-31 | 13G | RAPT Therapeutics, Inc. RAPT | The Vanguard Group | 366,550 2.220% | -27,951 (-7.09%) | Filing History |
| 2025-02-07 10:23 am Sale | 2025-01-31 | 13G | RAPT Therapeutics, Inc. RAPT | FMR LLC | 60,063 0.400% | -594,377 (-90.82%) | Filing History |
| 2025-01-06 6:38 pm Purchase | 2024-12-27 | 13G | RAPT Therapeutics, Inc. RAPT | BIOTECHNOLOGY VALUE FUND L P | 1,470,500 8.700% | 1,470,500 (New Position) | Filing History |
| 2025-01-06 09:22 am Purchase | 2024-12-27 | 13G | RAPT Therapeutics, Inc. RAPT | Medicxi IV LP | 2,794,000 16.900% | 2,794,000 (New Position) | Filing History |
| 2025-01-03 4:08 pm Purchase | 2024-12-27 | 13G | RAPT Therapeutics, Inc. RAPT | TCG Crossover GP II, LLC | 1,649,139 9.990% | 1,649,139 (New Position) | Filing History |
| 2024-12-30 3:32 pm Purchase | 2024-12-23 | 13G | RAPT Therapeutics, Inc. RAPT | Foresite Capital Fund VI LP | 1,562,500 9.300% | 1,562,500 (New Position) | Filing History |